Not investment advice. Educational platform. See Disclaimer.
NYSE: ZTS
Zoetis Inc.
Healthcare | Drug Manufacturers - General
$75.27-1.02 (-1.34%)as of 2026-09-04 15:42 UTC
Market Cap$31.6B
Volume1.04M
EPS (TTM)$6.02
Zoetis Inc. (NYSE: ZTS) is a $31.6B drug manufacturers - general company trading at $75.27 (−1.3% today) — 12.5× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-09-04 15:42 UTC.
52-Week Range
Low $71.02High $119.68
What Zoetis Inc. does
The company manufactures and distributes animal health products sold in more than 100 countries, with some products produced at sole-source manufacturing sites where minor deviations can cause delays or recalls. The company's success depends on maintaining customer perceptions of product quality and safety, which contribute to brand loyalty even after patent protection expires. Revenue is significantly exposed to foreign currency fluctuations, with a substantial portion earned outside the U.S. dollar.
The company manufactures and distributes animal health products sold in more than 100 countries, with some products produced at sole-source manufacturing sites where minor deviations can cause delays or recalls.
What is ZTS's valuation?
ZTS trades at $75.27, 12.50× trailing earnings, as of 2026-09-04.
When did ZTS last file with the SEC?
Zoetis Inc.'s most recent SEC filing on record is a 8-K filed 2026-05-22. All filings link to their SEC EDGAR originals above.
Where does this data come from?
SEC EDGAR filings and public market data feeds, fetched 2026-09-04 15:42 UTC. This page is also available as JSON at /api/data?ticker=ZTS and is emitted with FAQPage structured data for machine reading.
For you
Charts, 10-year financials, peer comparison, screening and portfolio tracking for ZTS and 5,000+ tickers.
